Intranasal oxytocin as strategy for medication-enhanced psychotherapy of PTSD: Salience processing and fear inhibition processes

S.B.J. Koch, M. van Zuiden, L. Nawijn, J.L. Frijling, D.J. Veltman, M. Olff

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)242-256
JournalPsychoneuroendocrinology
Volume40
DOIs
Publication statusPublished - 2014

Cite this

@article{42391b1175644960af524c3400ef3ddd,
title = "Intranasal oxytocin as strategy for medication-enhanced psychotherapy of PTSD: Salience processing and fear inhibition processes",
author = "S.B.J. Koch and {van Zuiden}, M. and L. Nawijn and J.L. Frijling and D.J. Veltman and M. Olff",
year = "2014",
doi = "10.1016/j.psyneuen.2013.11.018",
language = "Undefined/Unknown",
volume = "40",
pages = "242--256",
journal = "Psychoneuroendocrinology",
issn = "0306-4530",
publisher = "Elsevier Limited",

}

Intranasal oxytocin as strategy for medication-enhanced psychotherapy of PTSD: Salience processing and fear inhibition processes. / Koch, S.B.J.; van Zuiden, M.; Nawijn, L.; Frijling, J.L.; Veltman, D.J.; Olff, M.

In: Psychoneuroendocrinology, Vol. 40, 2014, p. 242-256.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Intranasal oxytocin as strategy for medication-enhanced psychotherapy of PTSD: Salience processing and fear inhibition processes

AU - Koch, S.B.J.

AU - van Zuiden, M.

AU - Nawijn, L.

AU - Frijling, J.L.

AU - Veltman, D.J.

AU - Olff, M.

PY - 2014

Y1 - 2014

U2 - 10.1016/j.psyneuen.2013.11.018

DO - 10.1016/j.psyneuen.2013.11.018

M3 - Article

VL - 40

SP - 242

EP - 256

JO - Psychoneuroendocrinology

JF - Psychoneuroendocrinology

SN - 0306-4530

ER -